N0 W4RN1NG
Bluelighter
Tertiary amines which are attached to 2 carbons and one oxygen are known to preferentially and quickly become reduced to secondary amines, where the carbon bonds remain intact but the oxygen is reduced away.
Taking this mechanism to it's logistical extreme, we can theoretically abuse this system to create either:
A. Uncontrolled, but pharmacologically identical chemical versions for streamlined in-vitro research without obtaining the necessary DEA license to do so:
DiMDMA Ether
or
B. Uncontrolled Hybrid compounds which have an unusual synergistic effect without the need for separate chemicals:
MDMAI + MC Ether
Does anyone know of any potential consequences to this I have overlooked?
Taking this mechanism to it's logistical extreme, we can theoretically abuse this system to create either:
A. Uncontrolled, but pharmacologically identical chemical versions for streamlined in-vitro research without obtaining the necessary DEA license to do so:
DiMDMA Ether
or
B. Uncontrolled Hybrid compounds which have an unusual synergistic effect without the need for separate chemicals:
MDMAI + MC Ether
Does anyone know of any potential consequences to this I have overlooked?
